MedTrace Logo

The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO

NCT04727190 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2021-02-02

No results posted yet for this study

Summary

The aim of this study is to investigate the difference of efficacy and safety between transbronchial cryobiopsy (TBCB) and transbronchial forceps biopsy (TBFB) in the diagnosis of lung ground-glass opacity.

Conditions

  • Lung Ground-Glass Opacity

Interventions

PROCEDURE

Transbronchial Cryobiopsy

The eligible patient will be randomized to TBCB group to receive transbronchial cryobiopsy.

PROCEDURE

Transbronchial Forceps Biopsy

The eligible patient will be randomized to TBFB group to receive transbronchial forceps biopsy.

Sponsors & Collaborators

  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD, PhD · Shanghai Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-09-30
Completion
2021-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04727190 on ClinicalTrials.gov